IR@PKUHSC  > 北京大学第二临床医学院  > 血液科
学科主题临床医学
Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia
Huang, Xiao-Jun; Liu, Dai-Hong; Liu, Kai-Yan; Xu, Lan-Ping; Chen, Yu-Hong; Wang, Yu; Han, Wei; Chen, Huan
关键词Donor Lymphocyte Infusion Hla-mismatched Transplantation Haploidentical Hsct Gvhd Relapse Dli
刊名JOURNAL OF CLINICAL IMMUNOLOGY
2008-05-01
DOI10.1007/s10875-007-9166-z
28期:3页:276-283
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Immunology
研究领域[WOS]Immunology
关键词[WOS]BONE-MARROW-TRANSPLANTATION ; ACUTE MYELOID-LEUKEMIA ; VERSUS-HOST-DISEASE ; ACUTE LYMPHOBLASTIC-LEUKEMIA ; COLONY-STIMULATING FACTOR ; BLOOD PROGENITOR CELLS ; HEMATOLOGICAL MALIGNANCIES ; CHEMOTHERAPY ; THERAPY
英文摘要

We evaluated the safety and efficacy of donor lymphocyte infusion (DLI) with granulocyte colony-stimulating factor priming and short-term immumosuppressive agents for prophylaxis of relapse in patients with advanced leukemia after human leukocyte antigen (HLA)-mismatched T cell-replete hematopoietic stem cell transplantation (HCT). Twenty-nine patients received prophylactic DLI at a median 75 (33-120) days after HCT. Acute graft-vs-host disease (GVHD) grades 3-4 occurred in six patients, and all cases were controlled. Eleven patients were alive and relapse-free with a probability of leukemia-free survival (LFS) of 37.3 +/- 9.6% at 3 years. Chronic GVHD was associated with a lower relapse rate and higher probability of LFS. Prophylactic-modified DLI is feasible in patients with advanced leukemia to prevent relapse after HLA-mismatched HCT.

语种英语
WOS记录号WOS:000255956500011
Citation statistics
Cited Times:37[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/51737
Collection北京大学第二临床医学院_血液科
作者单位Peking Univ, Peoples Hosp, Inst Hematol, Beijing 100044, Peoples R China
Recommended Citation
GB/T 7714
Huang, Xiao-Jun,Liu, Dai-Hong,Liu, Kai-Yan,et al. Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia[J]. JOURNAL OF CLINICAL IMMUNOLOGY,2008,28(3):276-283.
APA Huang, Xiao-Jun.,Liu, Dai-Hong.,Liu, Kai-Yan.,Xu, Lan-Ping.,Chen, Yu-Hong.,...&Chen, Huan.(2008).Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia.JOURNAL OF CLINICAL IMMUNOLOGY,28(3),276-283.
MLA Huang, Xiao-Jun,et al."Modified donor lymphocyte infusion after HLA-mismatched/haploidentical T cell-replete hematopoietic stem cell transplantation for prophylaxis of relapse of leukemia in patients with advanced leukemia".JOURNAL OF CLINICAL IMMUNOLOGY 28.3(2008):276-283.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Huang, Xiao-Jun]'s Articles
[Liu, Dai-Hong]'s Articles
[Liu, Kai-Yan]'s Articles
百度学术
百度学术Similar articles in
[Huang, Xiao-Jun]'s Articles
[Liu, Dai-Hong]'s Articles
[Liu, Kai-Yan]'s Articles
必应学术
必应学术Similar articles in
[Huang, Xiao-Jun]'s Articles
[Liu, Dai-Hong]'s Articles
[Liu, Kai-Yan]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.